Cardiopulmonary exercise test in adults with prior Fontan operation: The prognostic value of serial testing

Alexander C Egbe1, David J Driscoll2, Arooj R Khan1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Insights

Serial cardiopulmonary exercise testing (CPET) can predict cardiovascular adverse events (CAEs) in adults with Fontan palliation. A decline in peak oxygen consumption (VO2) predicts CAE risk, aiding patient risk stratification.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Exercise Physiology

Background:

  • Patients with Fontan palliation face long-term risks of cardiovascular adverse events (CAEs), including death or cardiac surgery.
  • Identifying reliable predictors of CAEs is crucial for managing this complex congenital heart disease population.
  • Cardiopulmonary exercise testing (CPET) assesses cardiovascular and respiratory function during exercise.

Purpose of the Study:

  • To evaluate the prognostic value of cardiopulmonary exercise test (CPET) indices for predicting cardiovascular adverse events (CAEs) in adults with Fontan palliation.
  • To determine if serial CPET measurements can identify patients at higher risk for adverse cardiovascular outcomes.

Main Methods:

  • Retrospective review of adult Fontan patients who underwent treadmill CPET between 1994 and 2013.
  • Inclusion criteria required maximal effort on serial CPETs with at least a 3-year interval and no intervening CAE.
  • Analysis focused on changes in CPET indices, particularly peak oxygen consumption (VO2), and their association with CAE occurrence.

Main Results:

  • A total of 145 adult Fontan patients met the study criteria.
  • A decline in % predicted peak oxygen consumption (VO2) of ≥3 percentage points/year was the sole significant predictor of 5-year CAE risk (HR 1.86).
  • CAEs (death or cardiac surgery) occurred in 37% of patients within 8 years of follow-up.

Conclusions:

  • Serial cardiopulmonary exercise testing (CPET) provides prognostic information for cardiovascular adverse events (CAEs) in the adult Fontan population.
  • CPET, specifically the rate of decline in peak VO2, can be utilized for risk stratification in these patients.
  • This approach may aid in guiding clinical management and surveillance strategies for adults with Fontan palliation.
Abstract